Inquire Now

Indian Metrics

  • Global ophthalmology trial for uveitis
  • India started 12 months after other global sites.
  • Currently India has the maximal contribution towards the global patient pool.
  • The ratio of sites in India vs RoW was 1:3.
  • Project and site specific referral and recruitment strategies were utilized.
  • Site identification done by ELS.
  • Average enrollment per site was the highest from the Indian sites.
  • This was largely contributed by the presence of trained CRC at site.
  • With maximal enrollment globally ELS operations team managed to keep the open queries at a minimum.
  • Query resolution turn-around time was within 48 hours.
  • Dedicated ELS resources at each site resolve queries within timeline.

“Total number of screening, randomization, follow up and unscheduled visits completed by ELS team till date. This includes trials for all therapeutic areas. All protocol defined activities were completed on time during these visits 96% of these visits were on schedule or within the window period”.